Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Gastric Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Digestive System Neoplasm
Gastric Neoplasm

Cancer Family

Gastric Neoplasm

CI-CAN-00000185Explore in graph →

Non-malignant720 active trials4 approved drugs55 evidence items

NCIt: C3387
MeSH: D013274

Overview
Statistics
Survival
Genomics9
Variants & evidence55
Drugs24
Trials3258
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (193)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 176–193 of 193 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Gastroblastoma harbors a recurrent somatic MALAT1-GLI1 fusion gene.
· Mod Pathol · 2017 · PMID 28731043 · validated civic_curation pubmed
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence.
· Cancer Discov · 2011 · PMID 22389872 · validated civic_curation pubmed
Gastroblastoma mimics the embryonic mesenchyme of the foregut: a case report.
· Diagn Pathol · 2023 · PMID 36803776 · validated civic_curation pubmed
Gastroblastoma in old age.
· Histopathology · 2019 · PMID 31287169 · validated civic_curation pubmed
Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
· J Pathol · 1999 · PMID 10547574 · validated civic_curation pubmed
Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.
· Cell Cycle · 2014 · PMID 24841718 · validated civic_curation pubmed
Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials.
· Mol Cancer Ther · 2014 · PMID 24608574 · validated civic_curation pubmed
Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.

Showing 176–193 of 193 publications

← Previous
1
…
7
8
Next →

· PLoS One · 2012 · PMID 22808142 · validated civic_curation pubmed

Promoter methylation of cyclin D2 gene in gastric carcinoma.

· Int J Oncol · 2003 · PMID 14612939 · validated civic_curation pubmed

The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.

· J Transl Med · 2013 · PMID 24088382 · validated civic_curation pubmed

Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model.

· Anticancer Res · 2015 · PMID 26637881 · validated civic_curation pubmed

Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.

· Cancer Lett · 2013 · PMID 23340172 · validated civic_curation pubmed

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum.

· Br J Cancer · 2012 · PMID 22343617 · validated civic_curation pubmed

Guo et al. Nat Commun 2018

· 2018 · PMID 29670109 · validated cbioportal_study pubmed

Wang et al. Nat Genet 2014

· 2014 · PMID 24816253 · validated cbioportal_study pubmed

TCGA, Nature 2014

· 2014 · PMID 25079317 · validated cbioportal_study pubmed

Wang et al. Nat Genet 2011

· 2011 · PMID 22037554 · validated cbioportal_study pubmed

Kakiuchi et al. Nat Genet 2014

· 2014 · PMID 24816255 · validated cbioportal_study pubmed